Very interesting analyses about the virology of #Omicron, which may explain the faster spread of this variant.

According to a new lab study, Omicron infects & multiplies ~70x faster than the Delta variant and the wild type SARS-CoV-2 in the human bronchus, but not in the lung.
In this ex vivo study (press release), Michael Chan, Malik Peiris & John Nicholls et al. @hkumed show that at 24h after infection Omicron replicated ~70x faster than Delta in bronchus. Interestingly, it replicated ~10x less efficiently in the lung tissue. hkumed.hk/96b127/
Another analysis by @BalazsLab also supports these findings. In this lab study w/ pseudoviruses, Omicron showed greater ability to infect cells than other variants, which was ~ 4 times more infectious than the original strain, also more than Delta. medrxiv.org/content/10.110…
These preliminary laboratory analyses indicate that;
📍Omicron is significantly more transmissible than delta
📍Less efficient replication in the lungs may suggest lower severity, but severity in humans is not determined only by virus replication but also the host immune response
Important to note that first study is an ex vivo work, meaning that human tissue is used to look at virus replication in the lab. So, this is not a definitive but supportive finding & needs to be confirmed by clinical data as host immune response is absent in these studies.
Lay summary: These results indicate inherent transmissibility & replication advantage of Omicron (in addition to immune evasion) compared to delta. It also explains why it spreads quickly and outcompeted delta in SA, which fits w/ modelling assumptions.
For those asking whether this is good/bad news, simple answer: I don't know. While omicron may infect the lung cells less efficiently, a higher viral load may worsen immune response. We discussed the pathogenesis w/
@KindrachukJason @KrutikaKuppalli bmj.com/content/371/bm…
The only thing I am sure of is that omicron will spread so quickly through the population, making it likely impossible to contain even with the most stringent measures & giving us very little time over the next few weeks. So get your vaccines & boosters!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Muge Cevik

Muge Cevik Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @mugecevik

7 Dec
Important preliminary data from SA looking at whether vaccine elicited antibodies are still effective against #Omicron.

Good & bad news: There is a big drop in neutralisation activity, but it's partial & hybrid (vax + infection) holds fairly well. 🧵

This is a live virus neutralisation assay. Neutralisation studies can tell us whether levels of Ab in the blood (convalescent and vaccinated plasma) are high enough to prevent the virus from infecting cells in the lab.

.@sigallab & colleagues tested plasma from those who received vax only (orange) & those who had vax + previous infection (green) and showed a significant (~40x) decline in neutralisation activity, but this was not a complete escape & reduction was less in hybrid anti-sera.
Read 15 tweets
3 Dec
🦠 There’s a lot we don’t yet understand about Omicron, including its impact on immunity and what it means for vaccines. New data will be emerging over the next few wks, which could be misinterpreted w/o context. What we might expect & how to interpret the emerging data? 🧵(1/n)
1- Genomic data:
The biggest concern with omicron is that it contains >30 mutations in just the spike protein, the part which helps it enter human cells and the target for vaccines. This mutation profile is very different than other VOCs. (2/n) Image
There are plausible biological consequences of some of these mutations, but we don't really know the combined effect of all these mutations, so full significance of omicron is uncertain. (3/n) Image
Read 37 tweets
24 Aug
There is a lot of concern/confusion about vaccine effectiveness against the delta variant. How effective are the vaccines against Delta & how to interpret real-world observational data? So much misinformation is being circulated, so this thread brings key data together. 🧵(1/n)
Vaccine efficacy measures the relative reduction in infection/disease for the vaccinated vs unvaccinated arm. For instance, a vaccine that eliminates all risk would have an efficacy of 100%. Efficacy of 50% means you have a 50% reduced risk compared to an unvaxxed person. (2/n) Image
All studies assessing the performance of vaccines against Delta are based on real-world data (vaccine effectiveness), which are influenced by variant transmissibility, human behaviour, and immunity status of the population, therefore they require careful interpretation. (3/n) Image
Read 25 tweets
7 Feb
There is a lot of confusion about the efficacy of AstraZeneca/ChAdOx1 vaccine against COVID19 due to B.1.351 / 501Y.V2 - summarising the results of phase 1b/2a double-blind randomized trial conducted in South Africa (based on @GovernmentZA press conference).🧵(1/6)
Adults aged 18-65 years without severe comorbidities and HIV were recruited. It was designed to show >60% efficacy against symptomatic disease, but because only 2000 participants were recruited with 42 total events, this analysis was not statistically powered. (2/6) Image
In total, 1749 participants were recruited, the population enrolled was young and generally healthy; the prevalence of hypertension, respiratory disease, and diabetes was low. Therefore, it was not designed to assess efficacy against severe disease. (3/6) Image
Read 7 tweets
11 Jan
Concerns about outdoor transmission risk seem to be trending again. What is the risk of transmission outdoors and should we be more worried about outdoors with the new more-transmissible variant? 🧵(1/n)
The risk of transmission is complex and multi-dimensional. It depends on many factors: contact pattern (duration, proximity, activity), individual factors, environment (e.g. outdoor, indoor), socioeconomic factors, and mitigation measures in place. (2/n)(gov.uk/government/pub…\) Image
Transmission is facilitated by close proximity, prolonged contact, and frequency of contacts. So, the longer the time you spend with an infected person and the larger the gathering, the higher the risk is. (3/n) (academic.oup.com/cid/advance-ar…\) Image
Read 26 tweets
21 Dec 20
There are several reasons to think that the new UK #SARSCoV2 variant is an important one as it might be more contagious than other variants, but there are also some uncertainties. So much misinformation is being circulated, so this thread brings key data together. 🧵
1- Genomic data
In the UK, COG-UK undertakes sequencing of SARS-CoV-2 samples from ~ 10% of positive cases. This is an enormous effort, and helps scientists to identify mutations and track them over time. Here are some variants being tracked in the UK. 1/ cogconsortium.uk/wp-content/upl… Image
Over time, scientists have identified this new variant, called B.1.1.7 or VUI – 202012/01 (the first Variant Under Investigation in December 2020), which looked different than others. It has acquired 17 mutations compared to its most recent ancestor. 2/ virological.org/t/preliminary-… Image
Read 45 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(